p2e number: PACKAGE LEAFLET: INFORMATION FOR THE USER Bisolvon … · 2019. 6. 12. · BISOLVON is...

Post on 15-Feb-2021

0 views 0 download

Transcript of p2e number: PACKAGE LEAFLET: INFORMATION FOR THE USER Bisolvon … · 2019. 6. 12. · BISOLVON is...

  • PACKAGE LEAFLET: INFORMATION FOR THE USER

    Bisolvon® 4 mg/5 ml Oral Solution(bromhexine hydrochloride)

    Read all of this leaflet carefully before you start taking this medicine.•Keepthisleaflet.Youmayneedto readitagain.

    •Ifyouhaveanyfurtherquestions,askyourdoctororpharmacist.

    • This medicine has been prescribed foryou.Donotpassitontoothers. Itmayharmthem,eveniftheir symptomsarethesameasyours.

    • If any of the side effects gets troublesomeorserious,orifyounotice any side effects not listed in thisleaflet,pleasetellyourdoctororpharmacist.

    In this leaflet:1. WhatBISOLVON4mg/5mlOral

    Solutionisandwhatitisusedfor2. BeforeyoutakeBISOLVON

    4mg/5mlOralSolution3. HowtotakeBISOLVON4mg/5ml

    OralSolution4. Possiblesideeffects5. HowtostoreBISOLVON4mg/5ml

    OralSolution6. Furtherinformation

    1. WHAT BISOLVON 4 MG/5 ML ORAL SOLUTION IS AND WHAT IT IS USED FOR

    ThenameofyourmedicineisBISOLVON4mg/5mlOralSolution(calledBISOLVONinthisleaflet).BISOLVONcontainsamedicinecalledbromhexine.Thisbelongstoagroupofmedicinescalledmucolyticagents.

    BISOLVONhelpsyoutobreathemoreeasilywhenyouhavebreathingproblemssuchasbronchitisorsinusitis.Itworksbymakingyourmucusthinnersothatyoucangetridofitmoreeasily.

    2. BEFORE YOU TAKE BISOLVON 4 MG/5 ML ORAL SOLUTION

    Do not take BISOLVON if:•Youareallergic(hypersensitive)to

    bromhexine or any of the other ingredientsofBISOLVON(listedinSection6below)

    •Youarepregnant,likelytogetpregnant or are breast-feeding

    Donottakethismedicineifanyoftheaboveapplytoyou.Ifyouarenotsure,talktoyourdoctororpharmacist.

    If you think this medicine is not working well enough Ifyourmedicinedoesnotseemtobeworkingforyou,talktoyourdoctorassoonaspossible.DonottakeextraBISOLVONunlessyourdoctortellsyouto.

    If you take more BISOLVON than you shouldIfyoutakemoreofthismedicinethanyoushould,talktoadoctororgotoahospitalstraightaway.TakethemedicinecontainerwithyouevenifthereisnoBISOLVONleft.

    If you forget to take BISOLVON •Ifyouforgetadose,takeitassoonasyourememberit

    •However,ifitisnearlytimeforthenextdose,skipthemisseddose

    •Donottakeadoubledosetomakeupforaforgottendose

    4. POSSIBLE SIDE EFFECTSLikeallmedicines,BISOLVONcancausesideeffects,althoughnoteverybodygetsthem.Thefollowingsideeffects mayhappenwiththismedicine:

    Stop taking BISOLVON and see a doctor straight away if you notice any of the following serious side effects – you may need urgent medical treatment:• Seriousallergicreactionsthatmaycause swellingoffaceorthroat,wheezing orsuddendifficultiesinbreathing

    •Skinlesionssuchassevereblisteringorpeelingofyourskin,mouth,throat,nose,eyesandgenitals

    Ifyounoticeanyoftheabove,stoptakingBISOLVONandseeadoctorstraightaway.

    Other side effectsUncommon (affects less than 1 in 100 people)•Feelingsick(nausea)orbeingsick(vomiting)

    •Painintheupperpartofyourabdomen•Diarrhoea

    Rare (affects less than 1 in 1000 people)•Hypersensitivityreactions• Rash• Urticaria

    The following side effects can also happen but the frequency of these is not known•Anaphylacticreactionsincludinganaphylacticshock,angioedema(rapidlydevelopingswellingoftheskin,subcutaneous,mucosaorsubmucosaltissues)

    •Severecutaneousadversereactions(includingerythemamultiforme,Stevens-Johnsonsyndrome/toxicepidermalnecrolysisandacutegeneralisedexanthematouspustulosis)

    •Tightnessofyourchest•Pruritus

    Inaddition,anexpectedincreaseintheflowofmucussecretionwillresultfromtakingBISOLVON.

    Reporting of side effectsIfyougetanysideeffects,talktoyourdoctor,pharmacistornurse.Thisincludesanypossiblesideeffects notlistedinthisleaflet.Youcan also report side effects directly (see detailsbelow).Byreportingsideeffectsyoucanhelpprovidemoreinformationonthesafetyofthismedicine.

    IrelandHPRAPharmacovigilanceEarlsfort TerraceIRL–Dublin2Tel:+35316764971Fax:+35316762517Website:www.hpra.iee-mail:medsafety@hpra.ie

    MaltaADRReportingTheMedicinesAuthorityPost-LicensingDirectorateSirTemiŻammitBuildings,MaltaLifeSciencesPark,SanĠwannSĠN3000,MaltaWebsite: www.medicinesauthority.gov.mt/adrportale-mail: postlicensing.medicinesauthority@gov.mt

    320017-14

    Technical colorsDiecut-Legendcase Free area Glue points

    File informationGMID code: 651884

    Plant PM code: 1060026612

    Second Plant PM code: 320017-14

    Version of artwork: V2

    PM type: PI

    Market: IE

    Format: 210 x 270 mm

    Issue date of artwork: 12/Mar/2019

    Print colors: Pan Black

    Number of print colors: 1

    Used font: Arial

    Min. font size: 9 pt

    p2e number: 922102

  • Take special care with BISOLVON Checkwithyourdoctororpharmacistbeforetakingyourmedicineif:•Youhaveorhaveeverhadastomachulcer

    Ifthisappliestoyou(oryouarenotsure),talktoyourdoctororpharmacistbeforetakingBISOLVON.

    Therehavebeenreportsofsevereskinreactionsassociatedwiththeadministration of bromhexine hydrochloride.Ifyoudevelopaskinrash(includinglesionsofthemucousmembranessuchasmouth,throat,nose,eyes,genitals),stopusingBISOLVONandcontactyourdoctorimmediately

    Taking other medicinesPleasetellyourdoctororpharmacistifyouaretakingorhaverecentlytakenanyothermedicines.Thisincludesmedicinesthatyoubuywithoutaprescriptionandherbalmedicines. ThisisbecauseBISOLVONcanaffectthewaysomeothermedicineswork.Also some other medicines can affect thewayBISOLVONworks.

    Inparticulartellyourdoctororpharmacistifyouaretakingany:•Antibioticssuchasampicillin,amoxicillin,erythromycinoroxytetracycline

    Pregnancy and breast-feedingDonottakeBISOLVONifyouarepregnant,likelytogetpregnantorifyouarebreast-feeding.

    Driving and using machinesNostudiesontheeffectontheabilitytodriveandusemachineshavebeenperformedwithBISOLVON.

    Important information about some of the ingredients of BISOLVON BISOLVONcontainsmaltitolliquid(E965).Whentakenaccordingtothedosagerecommendations,each5mldosesuppliesupto2.5gofmaltitolliquidwhichhasacalorificvalueof5.75Kcal.

    Themaltitolliquidintheproductmayhaveamildlaxativeeffect.

    Thismedicinecontains6.35mgbenzoic acidineach5ml.

    Youshouldnottakethisproductifyouhavebeentoldbyyourdoctorthatyouhaveanintolerancetofructose(atypeofsugar).Ifindoubtaskyourdoctororpharmacist.

    3. HOW TO TAKE BISOLVON 4 MG/5 ML ORAL SOLUTION

    Alwaystakethismedicineexactlyasyourdoctorhastoldyou.Youshouldcheckwithyourdoctororpharmacist ifyouarenotsure.

    Taking this medicineTakethismedicineonlybymouth. Itcanbetakenwithorwithoutfood.•Tomakesureyouusetherightamount,usethemeasuringcupprovidedtomeasureyourdose

    •Ifyouprefer,youcanaskyourpharmacistfora5mlplasticspoon touseinstead

    •Removethemeasuringcupfromthebottlecapbeforeuse

    •Fillthemeasuringcupuptothe5mlline

    •Rinsethemeasuringcupwithwaterafteruse

    How much to take

    Children from 2 up to and including 5 years•Theusualdoseis5mltwotimesaday

    Children over 5 up to and including 12 years•Theusualdoseis5mlfourtimesaday

    Adults and children over 12 years•Theusualdosestartsfrom10ml

    three times a day •However,youcouldbeaskedtotakeupto15mlfourtimesaday. Yourdoctorwilltellyouexactlyhowmuchyouneedtotake

    5. HOW TO STORE BISOLVON 4 MG/5 ML ORAL SOLUTION

    Keepoutofthesightandreachofchildren.

    Donotusethismedicineaftertheexpirydatewhichisstatedonthepackaging.Theexpirydatereferstothelastdayofthemonth.

    Donotusethismedicineifthebottlehasbeenopenfor12months.

    BISOLVONshouldbekeptintheoriginalcontainer.

    Medicinesshouldnotbedisposedofviawastewaterorhouseholdwaste.Askyourpharmacisthowtodisposeofmedicinesnolongerrequired.Thesemeasureswillhelptoprotecttheenvironment.

    6. FURTHER INFORMATION

    What BISOLVON contains•Each5mlofyourmedicinecontains4mgoftheactivesubstancebromhexine hydrochloride

    • The other ingredients are maltitol liquid(E965),sucralose(E955),benzoicacid(E210),cherryaroma,chocolatearoma,levomentholandpurifiedwater.

    What BISOLVON looks like and contents of the packBISOLVONisaclear,almostcolourlesssolutionwithafruityodour.Yourbottlecontainseither100ml,200mlor250 mlofliquid.Eachbottleisprovided withameasuringcup,togetherinacarton.

    Notallpacksizesmaybemarketed.

    Marketing Authorisation Holder and ManufacturerTheMarketingAuthorisationforBISOLVONisheldby:

    Irelandsanofi-aventisLtd.T/ASANOFICitywestBusinessCampus, Dublin24,Ireland.Tel:+35314035600Fax:+35314035687Email:IEmedinfo@sanofi.com

    MaltaSanofiMaltaLtd.,Level2, FortBusinessCentre,MriehelBypass,BirkirkaraBKR3000,Malta.Tel:+35621493022Email: PharmacovigilanceMalta@sanofi.com

    andtheBISOLVONismanufacturedby:

    DelpharmReimsS.A.S.10RueColonelCharbonneaux51100ReimsFrance

    Thisleafletwasrevisedin February2019.

    320017-14